ArticleInvestigational new drugs2023

Complete Response to tenalisib and romidepsin with long-term maintenance using tenalisib monotherapy in a patient with relapsed and refractory sézary syndrome.

Christopher N Nguyen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.